10/08/2014 - 9:04am

The Pharmaceutical Research and Manufacturers of America on Tuesday released a new report highlighting the number of investigational cancer medicines that did not succeed in clinical trials. 

10/07/2014 - 11:52am

Actavis and Durata Therapeutics on Monday announced that they have entered into a definitive merger agreement.

10/07/2014 - 11:52am

Biopharmaceutical company Chimerix on Monday announced that brincidofovir has been provided for potential use in patients with Ebola virus at the request of treating physicians.

10/07/2014 - 10:36am

America’s biopharmaceutical research companies are currently developing nearly 800 new medicines and vaccines for cancer, according to a new PhRMA report.

 

10/07/2014 - 9:47am

Sandoz announced the launch of its dexmedetomidine hydrochloride injection, a generic version of Precedex from Hospira. 

10/06/2014 - 4:35pm

Specialty drug spending continues to rise and is predicted to grow by more than 16% annually from 2015 to 2018. CVS Health researchers examine the reasons for such dramatic increases in spending and discuss tools to help manage these escalating costs.

10/06/2014 - 11:43am

Mylan announced the launch of its lamivudine and zidovudine tablets USP, in 150-mg dosage strength.

10/06/2014 - 10:13am

Healthcare Distribution Management Association released a statement in support of the FDA’s “Know Your Source” campaign.

10/06/2014 - 9:57am

Seven influenza vaccine manufacturers projected that as many as 151 million to 159 million doses of influenza vaccine will be available for use in the United States.